Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
BIO26-046: Validating an LLM for Detecting Enrollment Disparities in Breast Cancer Trials.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: April 30, 2026
BIO26-046: Validating an LLM for Detecting Enrollment Disparities in Breast Cancer Trials.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 30, 2026
The evolving landscape of CDK inhibitor use in breast cancer therapy and beyond.
Journal: Nature reviews. Drug discovery
Published: March 25, 2026
Racial and ethnic disparities in clinical outcomes of HER2-positive metastatic breast cancer treated with antibody-drug conjugates.
Journal: Journal of the National Cancer Institute
Published: February 28, 2026
Real-World Plasma Thymidine Kinase Activity in High-Risk and Metastatic Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Treated With Cyclin-Dependent Kinase 4/6 Inhibitors.
Journal: JCO precision oncology
Published: January 23, 2026
Area deprivation index and breast cancer outcomes among patients in Western New York.
Journal: Breast cancer research and treatment
Published: February 18, 2025
Results of a patient-level pooled analysis of three studies of trastuzumab deruxtecan in HER2-positive breast cancer with active brain metastasis.
Journal: ESMO open
Published: September 24, 2024
Estrogen Signaling in Early-Stage Breast Cancer: Impact on Neoadjuvant Chemotherapy and Immunotherapy.
Journal: Cancer treatment reviews
Published: September 10, 2024
Pure estrogen receptor antagonists potentiate capecitabine activity in ESR1-mutant breast cancer.
Journal: NPJ breast cancer
Published: December 21, 2023
RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 24, 2023
Keeping It in the Family: HER3 as a Target in Brain Metastases.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 28, 2023
Last Updated: 09/26/2026